首页> 外文OA文献 >Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies

【2h】

Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies

机译：通过抗因子IX抗体增强活性凝血因子IX的酶活性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
F. SCHEIFLINGER; M. DOCKAL; J. ROSING; R. J. KERSCHBAUMER;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies. [J] . Scheiflinger F, Dockal M, Rosing J, Journal of thrombosis and haemostasis: JTH . 2008,第2期

机译：抗凝血因子IX抗体增强了活化凝血因子IX的酶活性。
2. Discontinuous residues of factor IX constitute a surface for binding the anti-factor IX monoclonal antibody A-5. [J] . Chang YJ, Wu HL, Hsu YC, Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2003,第4a5期

机译：IX因子的不连续残基构成用于结合抗IX因子单克隆抗体A-5的表面。
3. Coagulation factor IX residues G(4)-Q(11) mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex [J] . Ahmad SS., Rawala R., Jameson BA., Biochemistry . 1998,第6期

机译：凝血因子IX残基G（4）-Q（11）介导其与活化血小板上的共享因子IX / IXa结合位点的相互作用，但不结合功能因子X激活复合物的装配
4. Construction and Expression of Human Coagulation Factor IX in the Pichia Pastoris [C] . Dai Yonggang, Wang Zhenyu, Wu Chenyu, 2010 4th International Conference on Bioinformatics and Biomedical Engineering . 2010

机译：人凝血因子IX在毕赤酵母中的构建及表达
5. Production of recombinant human coagulation factor IX by transgenic pig [D] . Xu, Weijie 2014

机译：转基因猪生产重组人凝血因子IX
6. Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha factor IXa beta and activated factor IX Chapel Hill. [O] . M J Griffith, L Breitkreutz, H Trapp, 1985

机译：表征结构上不同形式的活化因子IX的凝血活性。正常人IXaα因子IXaβ因子和活化的IX因子Chapel Hill的酶学性质。
7. Novel Insights and New Developments Regarding Coagulation Revealed by Studies of the Anti-Factor IXa (Activated Factor IX)/Factor X Bispecific Antibody, Emicizumab [O] . Koji Yada, Keiji Nogami 2020

机译：关于抗因子IXA（活性因子IX）/因子x双特异性抗体，Emicizumab的抗凝血的新颖见解和新的发展

Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies

著录项

引文网络

相似文献

相关主题

期刊订阅